Diabetes Treatment Flashcards
Ultra short-acting insulin
Aspart (Novolog), Lispro (Humalog), Glulisine (Apidra)
Short acting insulin
Regular insulin (Humilin)
Intermediate insulin
NPH (Humulin N)
Long acting insulin
Glargine (Lantus), Detemir (Levemir)
Ultra long acting insulin
Degludec (Tresiba)
C- peptide
Endogenously produced insulin is cleaved from proinsulin to active form plus C-peptide
IV insulin
Regular insulin is used as the IV formulation. aspart, glulisine, and lispro are all approved for intravenous use
Temperature effect on absorption
Increase
Exercise/massage effect on absorption
increase
Advantages of short acting insulin
Decreases post prandial hypoglycemia and superior post prandial lowering of BS, fewer occurrences of hypoglycemia, flexability
Disadvantages of short acting insulin
risk of hypoglycemia if no meal within 15 minutes, will need to combine with longer acting, if mixed with another give immediately after mixing, hyperglycemia/ ketosis may occur more rapidly
Advantages of long acting insulin
24 hr coverage with constant absorption pattern and no pronounced peak
Disadvantages of long acting
+ cancer risk (breast possible colon and pancreatic) for glargine use. cant be mixed with other insulin
Insulin dosing for T1
0.5-0.6U/kg/day
Basal insulin
1-2 doses of long-acting or NPH